Abstract
Persistent infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high gastric cancer risk, but has also been linked to protection from allergic, chronic inflammatory and autoimmune diseases. In the course of tens of thousands of years of co-existence with its human host, H. pylori has evolved elaborate adaptations that allow it to persist in the hostile environment of the stomach in the face of a vigorous innate and adaptive immune response. For this review, we have identified several key immune cell types and signaling pathways that appear to be preferentially targeted by the bacteria to establish and maintain persistent infection. We explore the mechanisms that allow the bacteria to avoid detection by innate immune cells via their pattern recognition receptors, to escape T-cell mediated adaptive immunity, and to reprogram the immune system towards tolerance rather than immunity. The implications of the immunomodulatory properties of the bacteria for the prevention of allergic and auto-immune diseases in chronically infected individuals are also discussed.
Highlights
Persistent infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high gastric cancer risk, but has been linked to protection from allergic, chronic inflammatory and autoimmune diseases
While H. pylori DNA activates TLR9 expressed on dendritic cells (DCs) in vitro [10], TLR9-/- mice do not differ from wild type mice in their ability to control H. pylori infections [11]
The authors later demonstrated through a biochemical approach that the secreted g-glutamyl transpeptidase (GGT) of H. pylori is the responsible factor for inhibition of T-cell proliferation; mutagenesis of GGT abrogated the inhibitory effect of the bacteria and recombinantly expressed GGT enzyme showed anti-proliferative activity [34]
Summary
Persistent infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high gastric cancer risk, but has been linked to protection from allergic, chronic inflammatory and autoimmune diseases. While H. pylori DNA activates TLR9 expressed on dendritic cells (DCs) in vitro [10], TLR9-/- mice do not differ from wild type mice in their ability to control H. pylori infections [11].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.